Sensus Healthcare, Inc. (SRTS): R&D Expense
$7.78M
Year ended 2025-12-31
$6.40M
Trailing 12 months to 2026-06-30
+31.0%
3-year compound annual growth
+13.3%
5-year compound annual growth
+18.2%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.78M | +84.5% | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | $4.22M | +14.6% | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | $3.68M | +6.3% | 2025-03-05, From 2023-01-01 |
| 2022-12-31 | $3.46M | +0.7% | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | $3.44M | -17.4% | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | $4.16M | -35.2% | 2022-03-25, From 2020-01-01 |
| 2019-12-31 | $6.42M | +2.5% | 2021-03-05, From 2019-01-01 |
| 2018-12-31 | $6.26M | +14.0% | 2020-03-06, From 2018-01-01 |
| 2017-12-31 | $5.49M | +201.0% | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | $1.82M | +24.4% | 2018-02-15, From 2016-01-01 |
| 2015-12-31 | $1.47M | n/a | 2017-03-10, From 2015-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | 2025-12-31 | $7.78M | +84.5% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $58.19M | +35.9% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $20.13M | +226.0% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $13.79M | -43.0% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $13.90M | +12.1% |
| Retractable Technologies Inc (RVP) | 2025-12-31 | $675.6K | +0.2% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $668.0K | -17.8% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $2.27M | +25.2% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $642.0K | -5.0% |
Compare SRTS, OBIO, BDMD, DRIO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗